5th NovAliX Conference - Biophysics in Drug Discovery 2018 Boston, Massachusetts, USA 13-15 June 2018

Description:
The use of biophysical methods has become pervasive in the drug discovery process, allowing not only to identify low-affinity hits at the screening stage but also to obtain detailed information on target / ligand interactions at more advanced stages (see the review Renaud et al. 2016 Nat. Rev. Drug Discov. 15: 679-698). This is perfectly illustrated by the success of FBDD (fragment-based drug design), where the progress of biophysical techniques in terms of sensitivity, speed, and automation has been instrumental (see the review Erlanson et al. 2016 Nat. Rev. Drug Discov. 15: 605-619). Indeed FBDD is now widely adopted in both academia and the pharmaceutical industry and has lead to 2 approved drugs and more than 30 compounds being evaluated in clinical trials.

Booking https://go.evvnt.com/197417-0?pid=4440

Prices:
Student and post-doctoral student (Early): USD 530
Academic (Early): USD 895
Industry affiliated (Early): USD 1625
Student and post-doctoral student (Late): USD 636
Academic (Late): USD 1074
Industry affiliated (Late): USD 1950
Student and post-doctoral student (Standard): USD 763
Academic (Standard): USD 1289
Industry affiliated (Standard): USD 2340

Speakers: Prof. Martin KARPLUS, Dr Tapan K. DAS, Dr Karyn T. O'NEIL, Prof. Jim WELLS, Dr Bridget CARRAGHER, Dr Gabriel LANDER, Dr Giovanna SCAPIN, Dr Chaohong SUN, Dr Miles CONGREVE, Prof. Shaomeng WANG, Prof. Adrian WHITTY, Prof. Jack TAUNTON, Prof. Masoud VEDADI

Time: on Wednesday June 13, 2018 at 9:30 am (ends Friday June 15, 2018 at 12:00 pm)